Noninvasive Biomarker Testing for Liver Fibrosis: The Laboratory's Role in Advancing MASLD and MASH Patient Management
Tracking # 20-1337286
Price not reported
There are no ratings for this course
Learn moreCourse overview
This webinar will explore the growing burden of MASLD and MASH in the US with an emphasis on the urgent need for early detection to improve patient outcomes. Attendees will gain insights into the expanding role of noninvasive blood-based biomarker testing for MASLD and MASH management. Drawing on real-world experience from the Mayo Clinic, Dr Nikola Baumann will provide laboratory validation strategies, cross-lab comparisons, and reporting considerations for novel noninvasive blood-based tests to ensure clarity and clinical confidence for both clinicians and patients.
Subject areas
This course counts toward the state boards and subject areas below.
American Board of Clinical Chemistry
Clinical Chemistry Diplomate
Molecular Diagnostics Diplomate
Toxicological Chemistry Diplomate
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported financial relationships:
- Nikola Baumann, PhD, DABCC
- Honorarium/Expenses: Siemens Healthineers